Evonik has concluded the sale of its triacetonamine (TAA) derivatives business to Sabo, an Italian chemical company, which subsequently acquired two production sites in Marl, Germany, and Liaoyang, China.

Sabo manufactures light stabilizers and uses TAA derivatives as a raw material. The TAA business was part of Evonik’s Specialty Additives Division.

Details on the price of the sale were not disclosed. The transaction was announced in mid-October, and the closing took place on December 29, 2022. Around 250 Evonik employees will transfer to Sabo.

“We want to continue our profitable growth in the specialty chemicals businesses,” said Christian Kullmann, chairman of the executive board of Evonik. “And that includes divesting businesses that no longer fit to our strategic focus and that could have a better future with new owners.”